Clinical Trial Update: Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating a beta-agonist as adjuvant therapy in Myasthenia Gravis across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Snippet

Sponsor: University of Aarhus | Conditions: Myasthenia Gravis | Phase 2, Phase 3 | Status: UNKNOWN